Tumor Antigens Help Explain Varied Reactions to Immunotherapy (4 of 5) (IMAGE)
Caption
Cancer Research UK scientists have now discovered rare immune cells inside tumors that recognize an evolved tumor's early, shared features. If these cells could be isolated, and artificially multiplied in the lab, they could form a fearsome cancer-fighting force. This material relates to a paper that appeared in the March 3, 2016, online issue of Science, published by AAAS. The paper, by N. McGranahan at The Francis Crick Institute in London, UK, and colleagues was titled, 'Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade.'
Credit
Cancer Research UK, produced by Phospho Biomedical Animation
Usage Restrictions
Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.
License
Licensed content